The firm prefers to invest and support early and mid-stage companies that focus on immunotherapy, cancer, metabolism, microbiome, autoimmune diseases, and drug delivery platforms.
The notable investment portfolio of Arkin Bio Ventures includes ARTSaVIT, Keros Therapeutics, Metabomed, Oncorus, Pi Therapeutics, Werewolf Therapeutics. As of January 2020, Arkin Bio Ventures has made 10 investments.
Pini Orbach Ph.D
Documentaries, videos and podcasts